Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Researchers say a medication originally used for epilepsy may significantly reduce breathing interruptions in people with sleep apnea, raising the possibility of a pill-based treatment.

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Right-size your expectations.

A European clinical trial finds the drug sulthiame can cut breathing interruptions in sleep apnea, offering hope for a ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more comfortable alternative is on the horizon. In a recent clinical drug trial that ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...